Post‐Procedural Troponin Elevation and Clinical Outcomes Following Transcatheter Aortic Valve Implantation

Author:

Koskinas Konstantinos C.1,Stortecky Stefan1,Franzone Anna1,O'Sullivan Crochan J.1,Praz Fabien1,Zuk Katazyrna1,Räber Lorenz1,Pilgrim Thomas1,Moschovitis Aris1,Fiedler Georg M.2,Jüni Peter3,Heg Dik4,Wenaweser Peter1,Windecker Stephan1

Affiliation:

1. Department of Cardiology, Bern University Hospital, Bern, Switzerland

2. Center for Laboratory Medicine, Inselspital, University Hospital Bern, Bern, Switzerland

3. Institute of Primary Health Care, University of Bern, Switzerland

4. Institute of Social and Preventive Medicine, University of Bern, Switzerland

Abstract

Background Biomarkers of myocardial injury increase frequently during transcatheter aortic valve implantation ( TAVI ). The impact of postprocedural cardiac troponin ( cT n) elevation on short‐term outcomes remains controversial, and the association with long‐term prognosis is unknown. Methods and Results We evaluated 577 consecutive patients with severe aortic stenosis treated with TAVI between 2007 and 2012. Myocardial injury, defined according to the Valve Academic Research Consortium ( VARC )‐2 as post‐ TAVI cardiac troponin T (cTnT) >15× the upper limit of normal, occurred in 338 patients (58.1%). In multivariate analyses, myocardial injury was associated with higher risk of all‐cause mortality at 30 days (adjusted hazard ratio [ HR ], 8.77; 95% CI , 2.07–37.12; P =0.003) and remained a significant predictor at 2 years (adjusted HR , 1.98; 95% CI , 1.36–2.88; P <0.001). Higher cTnT cutoffs did not add incremental predictive value compared with the VARC ‐2–defined cutoff. Whereas myocardial injury occurred more frequently in patients with versus without coronary artery disease ( CAD ), the relative impact of cTnT elevation on 2‐year mortality did not differ between patients without CAD (adjusted HR , 2.59; 95% CI , 1.27–5.26; P =0.009) and those with CAD (adjusted HR , 1.71; 95% CI , 1.10–2.65; P =0.018; P for interaction=0.24). Mortality rates at 2 years were lowest in patients without CAD and no myocardial injury (11.6%) and highest in patients with complex CAD ( SYNTAX score >22) and myocardial injury (41.1%). Conclusions VARC ‐2–defined cTnT elevation emerged as a strong, independent predictor of 30‐day mortality and remained a modest, but significant, predictor throughout 2 years post‐ TAVI . The prognostic value of cTnT elevation was modified by the presence and complexity of underlying CAD with highest mortality risk observed in patients combining SYNTAX score >22 and evidence of myocardial injury.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3